Protein Nanoparticles with Enzymatic and Antigen-Binding Activities Induce Th1 Cytokine Gene Expression

Article Preview

Abstract:

To improve protein stability and membrane permeability the protein nanoparticles (NP) were fabricated from enzymes or virus-specific antibodies by nanoprecipitation. Lysozyme NP destroyed bacterial cellular walls. RNase-based NP hydrolyzed RNA. Lipase, catalase and horseradish peroxidase activities were also registered for corresponding protein NP. NP from polyclonal antibodies against the influenza A virus and monoclonal antibodies against hemagglutinin H1, H3; proteins NS and NP could interact with their specific antigens. NP from monoclonal antibodies against the hepatitis B surface antigen bound with the antigen as shown by ELISA. The protein NP were stable in water at 4°C for several months and in the presence of blood sera or saliva for more than 5 days. The protein NP were not toxic for human cells and mice. The protein NP could penetrate and accumulate in cells in 2 hours with maximum after 2 days and subsequent gradual decline until background values. Entry of foreign protein NP into the eukaryotic cells induced cytokine gene expression. RNA of interferon (IFN) a, b and l but not IFN g were detected by reverse transcription with real time PCR. Polarization index (Th2:Th1 cytokine RNA) was near 0. Accordingly, cellular uptake of non-toxic protein NP induced Th1 polarization of immune response.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

109-113

Citation:

Online since:

June 2020

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2020 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] D. Bobo, K.J. Robinson, J. Islam, K.J. Thurecht, S.R. Corrie: Pharm Res. Vol. 33(10) (2016), p.2373.

Google Scholar

[2] W. Lohcharoenkal, L. Wang, Y.C. Chen, Y. Rojanasakul: Biomed Res Int. (2014), p.180549.

Google Scholar

[3] O.V. Morozova, E.R. Pavlova, D.V. Bagrov, N.A. Barinov, K.A. Prusakov, E.I. Isaeva, V.V. Podgorsky, D.V. Basmanov, D.V. Klinov: International Journal of Nanomedicine Vol. 13 (2018), p.6637.

DOI: 10.2147/ijn.s177627

Google Scholar

[4] O.V. Morozova, T.P. Ospelnikova. Patent 2016131205, 28.07.2016. Ru 2 627 179. C12Q 1/68 (2006.01).

Google Scholar

[5] A. H. Ummu, Z. H. Mohd, B.A. Noorjahan, A. Ya. A.Syazaira, J.M. Mas: International Journal of Nanomedicine Vol. 13 (2018), p.5075.

Google Scholar